Ravikirti (2021) “Evaluation of Ivermectin as a Potential Treatment for Mild to Moderate COVID-19: A Double-Blind Randomized Placebo Controlled Trial in Eastern India”, Journal of Pharmacy & Pharmaceutical Sciences, 24(3), pp. 343–350. doi: 10.18433/jpps32105.